DpC

N/A

Report date: 2024/12/18 14:17:49
NME

Base Information

Drug NameDpC
Drug Alias NameDp4cycH4mT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGene expression stimulantsCell death stimulantsReactive oxygen species stimulants +[5] 
TargetsReactive oxygen speciesN-Myc Downstream Regulated 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Sydney
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCollaborative Medicinal Development Pty Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A